#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Waldenstrom's macroglobulinaemia recurrent Angiosarcoma metastatic Soft tissue necrosis Bulbospinal muscular atrophy congenital Prolymphocytic leukaemia Emphysema Synovial sarcoma PIK3CA related overgrowth spectrum Huntington's disease Aicardi-Goutieres syndrome Round cell liposarcoma Undifferentiated sarcoma Congenital generalised lipodystrophy Infantile spasms Muscular dystrophy More trials…

    Learn about Rare Diseases

    Noonan syndrome Medulloblastoma recurrent Piriformis syndrome – Treatment Pulmonary sarcoidosis Piriformis syndrome – Basic Information IgA nephropathy Piriformis syndrome – Diagnostics Hyperoxaluria – Diagnostics Acquired haemophilia – Basic Information Sarcoidosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    D-Biotin X-396 Clemastine Tipapkinogene Sovacivec Methylone Incb000928 Sodium Picosulfate Gsk4527226 Chloroprocaine Hydrochloride Abemaciclib Pacritinib Vismodegib Balstilimab GSKVX000000034795 TRONTINEMAB Clazakizumab Vanglusagene Ensiparvovec Aldesleukin Fluoxetine AGANIRSEN More therapies…

    Learn about Your Condition

    Injury Microvillous inclusion disease Thalassaemia Mitochondrial myopathy Renal cancer recurrent Pharyngeal cancer stage I Solitary fibrous tumour Monkeypox Micrographic skin surgery Anaemia of chronic disease Acquired ATTR amyloidosis Anal cancer stage II Biliary cancer metastatic Cardiovascular disorder Malignant peritoneal neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Helse Fonna HF

Helse Fonna HF

Karmsundgata 120, Haugesund, 5528, Norway

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Dabrafenib, Trametinib, and Imatinib for Patients with Rare and Hard-to-Treat Cancers

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Dabrafenib
    • Vorasidenib
    • Trametinib
    Norway

  • Study on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Capmatinib
    • Ceritinib
    • Pemigatinib
    Norway

  • Study Comparing Avatrombopag and Rituximab for Adults with Immune Thrombocytopenia Not Responding to Corticosteroids

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Avatrombopag
    • Rituximab
    Norway

  • Study on Fasudil Hydrochloride for Memory Loss Prevention in Early Alzheimer’s Disease Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Fasudil Hydrochloride
    Norway

  • Study of Ambroxol Treatment in People with Early Stage or Mild Lewy Body Dementia

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Ambroxol Hydrochloride
    Norway

  • Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Bulgaria Czechia Denmark Finland France Germany +8

  • Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer limited stage
    Investigated Drugs:
    • Durvalumab
    Denmark Estonia Finland Germany Lithuania The Netherlands +2

  • Study on the Effects of Phenserine and Donepezil in Patients with Early or Mild Alzheimer’s Disease

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • (-)-PHENSERINE TARTRATE
    • Donepezil Hydrochloride
    Norway

  • Study on Personalized Treatment for High-Risk Breast Cancer Using Palbociclib, Olaparib, and Pertuzumab in Patients with Advanced Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Olaparib
    • Palbociclib
    • Pertuzumab
    Norway

  • Study on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary adrenal insufficiency
    Investigated Drugs:
    • Cortisone
    • Hydrocortisone
    Norway
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!